Role of Akt signaling in resistance to DNA-targeted therapy

doi:10.5306/wjco.v7.i5.352

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11430)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

698

WORD

383

HTML

5997

Figures (1-4)

344

Tables (1-4)

312

Sum=7734

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

660

Download

1068

Sum=1728

Publishing Process of This Article

Item

Count

Browse

817

Download

1151

Sum=1968

Oct 10, 2016 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (52)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Oct 10, 2016; 7(5): 352-369
Published online Oct 10, 2016. doi: 10.5306/wjco.v7.i5.352

Full Size Figure Download Figure

Figure 4 Review flow diagram of the publication selection in clinical category.

Citation: Avan A, Narayan R, Giovannetti E, Peters GJ. Role of Akt signaling in resistance to DNA-targeted therapy. World J Clin Oncol 2016; 7(5): 352-369
URL: https://www.wjgnet.com/2218-4333/full/v7/i5/352.htm
DOI: https://dx.doi.org/10.5306/wjco.v7.i5.352